GLPG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Galapagos NV (GLPG) is not a strong buy for a beginner investor with a long-term strategy at this time. The stock shows no significant positive catalysts, and technical indicators suggest a neutral to slightly bearish trend. While the company has shown improvement in revenue and net income, the overall financials remain weak, with negative EPS and declining gross margin. Analyst sentiment is neutral, and there are no recent influential trades or news to drive a strong bullish case. Given the lack of strong buy signals and the investor's preference for long-term growth, holding off on this investment is recommended.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 38.135, and moving averages are converging, showing no clear trend. The stock is trading near its support level of 33.298, with resistance at 34.642. Overall, the technical indicators suggest a neutral to slightly bearish trend.
Revenue increased by 18.90% YoY in Q3 2025, and net income improved significantly, up 300.78% YoY. The company has undergone a transformation into an investment-focused biotech business.
Gross margin declined by 15.21% YoY, EPS remains negative at -3.07, and the stock has a bearish short-term trend with a potential -1.98% decline over the next month. No significant news, insider, or hedge fund activity was reported recently.
In Q3 2025, revenue increased to $71.16M (up 18.90% YoY), net income improved to -$202.11M (up 300.78% YoY), and EPS increased to -3.07 (up 303.95% YoY). However, gross margin dropped to 84.76% (down 15.21% YoY).
Bernstein initiated coverage with a Market Perform rating and a price target of EUR 27.90, citing the company's transformation into an investment-focused biotech business. Analyst sentiment is neutral.
